Placebo (administration et posologie) < Plan de recherche (MeSH) < Plan de recherche (normes)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Plan de recherche (MeSH)

Number of relevant bibliographic references: 17.

Ident.	Authors (with country if any)	Title
000093 (2021)	Derek Shyr [États-Unis] ; Yu Shyr [États-Unis]	The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic.
000253 (2021)	Leila Simani [Iran] ; Mahtab Ramezani [Iran] ; Ilad Alavi Darazam [Iran] ; Mastooreh Sagharichi [Iran] ; Mohammad Amin Aalipour [Iran] ; Fatemeh Ghorbani [Iran] ; Hossein Pakdaman [Iran]	Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
000338 (2021)	Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni]	Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
000478 (2021)	Hardeep Kaur [Inde] ; Phulen Sarma [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Subodh Kumar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde]	Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
000521 (2021)	Daniela R. Junqueira [Canada] ; Brian H. Rowe [Canada]	Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.
000919 (2020)	Mariacarla Gadebusch Bondio [Allemagne] ; Maria Marloth [Allemagne]	[The "Historic Study" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic].
000926 (2020)	L. Boyer [France] ; P. Auquier [France] ; G. Fond [France]	[Real-life data and Covid-19: The third avenue of reseach].
000D33 (2020)	Mahir Fidahic [Bosnie-Herzégovine] ; Danijela Nujic [Croatie] ; Renata Runjic [Croatie] ; Marta Civljak [Croatie] ; Filipa Markotic [Croatie] ; Zvjezdana Lovric Makaric [Croatie] ; Livia Puljak [Croatie]	Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19.
000D44 (2020)	Julian D. Machiels [Pays-Bas] ; Chantal P. Bleeker-Rovers [Pays-Bas] ; Rob Ter Heine [Pays-Bas] ; Janette Rahamat-Langendoen [Pays-Bas] ; Quirijn De Mast [Pays-Bas] ; Jaap Ten Oever [Pays-Bas] ; Teun Bousema [Pays-Bas] ; Reinout Van Crevel [Pays-Bas] ; Heiman Fl Wertheim [Pays-Bas]	Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
000E86 (2020)	Javed Akram [Pakistan] ; Shehnoor Azhar [Pakistan] ; Muhammad Shahzad [Pakistan] ; Waqas Latif [Pakistan] ; Khalid Saeed Khan [Espagne]	Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.
000F27 (2020)	Magnus Nakrem Lyngbakken [Norvège] ; Jan-Erik Berdal [Norvège] ; Arne Eskesen [Norvège] ; Dag Kvale [Norvège] ; Inge Christoffer Olsen [Norvège] ; Anbj Rg Rangberg [Norvège] ; Christine Monceyron Jonassen [Norvège] ; Torbj Rn Omland [Norvège] ; Helge R Sj [Norvège] ; Olav Dalgard [Norvège]	Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
001354 (2020)	Yan Liu [République populaire de Chine] ; Xiaoxu Fu ; Chunguang Xie	Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
001467 (2020)	Richard C. Becker [États-Unis]	Covid-19 treatment update: follow the scientific evidence.
001617 (2020)	Robin E. Ferner [Royaume-Uni] ; Jeffrey K. Aronson [Royaume-Uni]	Chloroquine and hydroxychloroquine in covid-19.
001821 (2020)	Bin Wang [République populaire de Chine] ; Junkai Lai [République populaire de Chine] ; Xiaoyan Yan [République populaire de Chine] ; Feifei Jin [République populaire de Chine] ; Bin Yi [République populaire de Chine] ; Caixia An [République populaire de Chine] ; Yuanxiao Li [République populaire de Chine] ; Chen Yao [République populaire de Chine]	COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis.
001912 (2020)	Katheron Intson [Canada] ; Sachin Kumar [Canada] ; Amy Botta [Canada] ; Rachael Neckles [États-Unis] ; Connie Leung [Canada] ; Ali Jawaid [Pologne]	An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19.
001A17 (2020)	Md Sadakat Chowdhury [États-Unis] ; Jay Rathod [États-Unis] ; Joel Gernsheimer [États-Unis]	A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Plan de recherche (MeSH)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Plan de recherche (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Plan de recherche (MeSH)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021